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The development of chronic and recurrent Staphylococcus aureus infections is associated with the emergence of slow-growing
mutants known as small-colony variants (SCVs), which are highly tolerant of antibiotics and can survive inside host cells. How-
ever, the host and bacterial factors which underpin SCV emergence during infection are poorly understood. Here, we demon-
strate that exposure of S. aureus to sublethal concentrations of H2O2 leads to a specific, dose-dependent increase in the popula-
tion frequency of gentamicin-resistant SCVs. Time course analyses revealed that H2O2 exposure caused bacteriostasis in wild-
type cells during which time SCVs appeared spontaneously within the S. aureus population. This occurred via a mutagenic DNA
repair pathway that included DNA double-strand break repair proteins RexAB, recombinase A, and polymerase V. In addition to
triggering SCV emergence by increasing the mutation rate, H2O2 also selected for the SCV phenotype, leading to increased phe-
notypic stability and further enhancing the size of the SCV subpopulation by reducing the rate of SCV reversion to the wild type.
Subsequent analyses revealed that SCVs were significantly more resistant to the toxic effects of H2O2 than wild-type bacteria.
With the exception of heme auxotrophs, gentamicin-resistant SCVs displayed greater catalase activity than wild-type bacteria,
which contributed to their resistance to H2O2. Taken together, these data reveal a mechanism by which S. aureus adapts to oxi-
dative stress via the production of a subpopulation of H2O2-resistant SCVs with enhanced catalase production.
Staphylococcus aureus is a frequent cause of chronic and recur-rent infections, which often involve the emergence of slow-
growing mutants known as small-colony variants (SCVs) (1–14).
The majority of SCVs isolated from clinical samples are auxotro-
phic for hemin, menadione, or thymidine due to mutations in the
hem or men operons or in thyA, respectively (2, 4, 15–19). However,
SCVs with mutations conferring resistance to fusidic acid or which
arise via mutation in succinate dehydrogenase have also been identi-
fied, and there also appear to be isolates with a transient SCV pheno-
type, which are likely not mutants (12, 20, 21). SCVs with mutations
in heme or menaquinone biosynthetic pathways have defective elec-
tron-transport chains, which confers resistance to aminoglycoside
antibiotics such as gentamicin (1, 6, 8, 9).
Previous work has shown that gentamicin-resistant SCVs emerge
in replicating populations in the absence of environmental stress via
stochastic mutations but frequently revert to the wild type (WT) via
the acquisition of suppressor mutations (15, 17, 22). However, while
a few factors have been identified that select for the SCV phenotype,
there is also evidence that environmental stimuli can trigger the
emergence of SCVs in S. aureus populations, although the mecha-
nism(s) by which this occurs is unknown (12, 23, 24).
In addition to aminoglycoside resistance, SCVs that arise via
the loss of the electron transport chain are more tolerant than
wild-type bacteria of other classes of bactericidal antibiotics (8, 9,
25–29). Furthermore, SCVs exhibit other phenotypic characteris-
tics which may promote survival in host tissues, including elevated
rates of host cell invasion and intracellular survival, enhanced cap-
sule production, and robust biofilm formation (5, 12, 13, 30–32).
Several of these phenotypes are ascribed to a combination of de-
creased Agr activity and enhanced SigB activity, which results in
strong expression of surface proteins and an absence of cytolysin
production (16, 33–35).
However, there is one aspect of the biology of electron-trans-
port chain defective SCVs that appears to be at odds with a role in
chronic infection: an apparently reduced level of defense against
oxidative stress. This is important because the generation of reac-
tive oxygen species (ROS) such as O2
 and H2O2 by neutrophils is
a crucial host defense mechanism against S. aureus (36, 37). To
combat ROS, S. aureus uses a number of defensive molecules,
including catalase (KatA), superoxide dismutases (SodA/M), and
the golden pigment staphyloxanthin (36–44). Despite the impor-
tance of these defenses for wild-type S. aureus survival in the host,
SCVs have been reported to produce significantly reduced levels of
staphyloxanthin and heme auxotrophs are deficient in catalase,
which would be expected to make them more susceptible to ROS
generated by neutrophils and thus clearance from host tissues (9,
19, 28, 36, 45). Therefore, the aim of this work was to determine
the effect of ROS on the emergence and persistence of electron-
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transport chain defective SCVs within S. aureus populations and
establish the degree to which SCVs are sensitive to oxidative stress.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Strains used in the present
study are listed in Table 1. S. aureus was cultured in tryptic soy broth at
37°C with shaking as described previously (22). Broth cultures were inoc-
ulated with bacteria from stationary phase (105 CFU ml1), followed
immediately by oxidants or ciprofloxacin and incubated for 16 h at 37°C
with shaking at 180 rpm. Bacteria were used in stationary phase since this
is when pigmentation of the wild type is greatest (36). Transposon mu-
tants were cultured in the presence of erythromycin (10 g ml1), but
subsequent assays were performed in the absence of the antibiotic to re-
duce off-target effects. CFU counts were determined by serial dilution and
plating of aliquots onto tryptic soy agar (TSA) or Columbia blood agar
(CBA) with or without gentamicin (2 g ml1). SCVs were defined as
gentamicin-resistant (MIC  2 g ml1) bacteria that produced small,
slow-growing, nonhemolytic or weakly hemolytic, and nonpigmented or
weakly pigmented colonies on blood agar. We did not study other types of
SCVs, such as those resistant to sulfonamides or fusidic acid. DNA from
transposon mutants was transduced into wild-type SH1000 by transduc-
tion with 11 as described previously, and transductants bearing the in-
serted transposon were selected for on TSA containing erythromycin (10
g ml1) (46).
USA300-derived hemB and menD mutants (35) were complemented
by cloning the appropriate gene, under the control of the native promoter
of the relevant operon, into integrative plasmid pCL55 (47). For hemB, the
promoter region (48) was amplified by using the primer pair Hem Prom
For (CCTTTCGTCTTCAACGTATATTCATTGACCCG) and Hem
Prom Rev (GTCTATCAAATTTCATGTTCAATTCCTCCTAGG). For
menD, the 331 bases upstream of menF, the first gene in the men operon,
were amplified by using the primer pair Men Prom For (CCCTTTCGTC
TTCAATGAATACAAAACCTCTTTAAATC) and Men Prom Rev (CTT
TATGATTTCCCATATAAAAGCGATCTCCTGCC). Amplicons con-
taining promoter regions were fused with coding sequences by using the
Gibson assembly protocol (NEB). DNA overhangs were built into primers
(indicated in boldface) to facilitate recombination. The hemB gene was
amplified by using the primer pair Hem For (GGAGGAATTGAACATG
AAATTTGATAGACATAG) and Hem Rev (TACCGAGCTCGAATTCA
CCTTAATTATCTAAATAGC), while menD was amplified by using the
primer pair Men For (GGAGATCGCTTTTATATGGGAAATCATAAAG
CAG) and Men Rev (ACCGAGCTCGAATTCTTATAATGTGTCATGA
ATCATTTC). The vector, pCL55, was amplified by using primers with
overhangs to facilitate Gibson assembly. For hemB constructs, pCL55 was
amplified by using the primer pair pCL55 Hem For (AGATAATTAAGG
TGAATTCGAGCTCGGTACC) and pCL55 Hem Rev (AATGAATATAC
GTTGAAGACGAAAGGGCCTC), and for menD constructs, the primer
pair pCL55 Men For (CATGACACATTATAAGAATTCGAGCTCGG
TAC) and pCL55 Men Rev (AGAGGTTTTGTATTCATTGAAGACGAA
AGGG) was used.
The SH1000 umuC::Tn mutant was complemented with the umuC
coding sequence (including the promoter region) using pCN34 (49). The
umuC gene and the promoter region was amplified by using the primer
pair umuC For (AAAGGATCCCGGCGTCAGTTACTTCGC) and umuC
Rev (AAAGGATCCCGTATCGCGACGCACTAC), which included
BamHI restriction sites (underlined) to enable ligation into BamHI-di-
gested pCN34. Vector without the umuC coding sequence served as a
control. The successful generation of constructs was confirmed by DNA
sequencing. Vectors were constructed in Escherichia coli strain DC10B
and transformed directly into S. aureus strains (50). In the case of pCL55,
plasmid integration was confirmed by PCR. DC10B was cultured in LB
broth containing ampicillin (100 g ml1) where necessary to select for
plasmid maintenance (50). S. aureus strains containing plasmids were
cultured in the presence of 10g of chloramphenicol ml1 (pCL55) or 90
g of kanamycin ml1 (pCN34) and washed in phosphate-buffered saline
(PBS) to remove antibiotics, and experiments were performed in the ab-
sence of antibiotics to avoid off-target effects.
Hydrogen peroxide quantification. The concentration of H2O2 in
culture medium was determined by using a Pierce quantitative peroxide
assay kit according to the manufacturer’s instructions.
SCV stability assays. The stability of SCV isolates was determined as
described previously (22). SCV colonies (n  30 to 50) on TSA plates
containing 2 g of gentamicin ml1 were subcultured by streaking them
onto antibiotic-free TSA using a sterile pipette tip, followed by incubation
at 37°C for 48 h. Subsequently, subcultured bacteria were scored for re-
version. If all colonies in the subcultured streak retained the SCV pheno-
type, then that SCV was scored as stable. If all of the colonies had the WT
phenotype, the streak was scored as unstable. SCVs that generated a mix-
ture of SCV and WT phenotype were categorized as partially stable (22).
Phenotype-switching assay.To understand the relative contributions
of phenotype-switching and replication to determining the size of the
SCV population, we used a previously described assay (22). Briefly, inoc-
ula of 105 CFU tetracycline-sensitive wild-type SH1000 S. aureus and 10
CFU SH1000t tetracycline-resistant SCVs were cultured in the absence or
presence of oxidants. The total CFU were quantified by plating serial
dilutions on TSA plates. SCVs were isolated on TSA plates containing
gentamicin, as described above. Subsequently, 100 SCV colonies were
picked and patched onto TSA plates containing tetracycline to determine
the percentage of SCVs that were resistant to the antibiotic. This assay
determines the percentage of the final SCV population that arose from
wild-type or SCV bacteria in the inoculum. Previous work has shown that
the tetracycline-resistant strain does not suffer a fitness cost under the
conditions used (22).
SCV reversion assay. Individual SCV colonies were picked from TSA
plates containing gentamicin (2 g ml1) and resuspended in 150 l of
PBS. Aliquots (50 l) of each bacterial suspension were then spread over
TSA plates containing paraquat (0.1 mM), ciprofloxacin (0.05 g ml1),
or neither before incubation for 24 h at 37°C. Subsequently, plates were
examined for the presence of colonies of wild-type bacteria (large, pig-
mented colonies).
Mutation rate analyses. S. aureus strains were cultured in 3 ml of TSB
after inoculation from agar plates. Cultures were diluted to 105 CFU ml1
in 30 parallel 1-ml cultures (this was the smallest inoculum that allowed
bacterial growth in the presence of H2O2) and grown to stationary phase
at 37°C with shaking. Total CFU counts were determined in 10 randomly
selected cultures by plating of serial dilutions onto TSA without antibiot-
ics. Each culture was then plated onto TSA containing rifampin (100 g
ml1), followed by incubation for 24 h at 37°C. The number of resistant
colonies was counted, and mutation rates with confidence intervals were
calculated by using the maximum-likelihood setting of the FALCOR mu-
tation rate calculator (51, 52). The statistical significances of differences
between the mutation rate in the absence and presence of H2O2 were
determined by using a Student t test as described in equation 5 of
FALCOR (51, 52).
Hydrogen peroxide killing assays. S. aureus cells in late exponential
phase (when pigmentation is strongest) were washed by sequential rounds
of centrifugation and resuspension in PBS before subsequent adjustment
to a final concentration of106 CFU ml1 in PBS. Bacterial suspensions
(10l) were added to the wells of a microtiter plate, and H2O2 was added
to 30 mM for SH1000-derived isolates or 25 mM for USA300-derived
strains (this concentration was chosen because preliminary assays indi-
cated that they were the lowest required to achieve 1-log killing of the
wild-type over 1 h [data not shown]). The microtiter plate was incubated
at 37°C in the dark for 15 to 60 min. Surviving bacteria were enumerated
by serial dilution in PBS and plating onto CBA (which naturally contains
catalase to neutralize residual H2O2).
Catalase activity assay. S. aureus was grown and washed as described
above for hydrogen peroxide killing assays before 107 CFU were added to
1 ml of PBS containing 100 M H2O2. The concentration of H2O2 was
measured over time by using a Pierce quantitative peroxide assay kit in
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TABLE 1 Bacterial strains used in this study
Bacterial strain Relevant characteristicsa
Source or
reference
E. coli
DC10B DNA cytosine methyltransferase deficient 50
DC10B/pCN34 DC10B transformed with pCN34 49; this study
DC10B/pCL55 DC10B transformed with pCL55 47
DC10B/phemB DC10B transformed with pCL55 containing the promoter of the hem operon fused to the coding
sequence of hemB
DC10B/pmenD DC10B transformed with pCL55 containing the promoter of the men operon fused to the coding
sequence of menD
DC10B/pumuC DC10B transformed with pCN34 containing the promoter and coding region of umuC
S. aureus
SH1000 Functional rsbU derivative of NCTC 8325-4 66
SCV2 SH1000-derived Gmr SCV without auxotrophy for Men, Hem, Thy, CO2, or fatty acids; isolated in the
absence of oxidants
This study
SCV4 SH1000-derived Gmr SCV without auxotrophy for Men, Hem, Thy, CO2, or fatty acids; isolated in the
absence of oxidants
SCV9 SH1000-derived Gmr SCV with auxotrophy for Hem; isolated in the absence of oxidants
SCV13 SH1000-derived Gmr SCV with auxotrophy for CO2; isolated in the absence of oxidants
SCV14 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the absence of oxidants; single nucleotide
deletion in menB, leading to premature stop codon after 28 amino acids
SCV15 SH1000-derived Gmr SCV with auxotrophy for fatty acids; isolated in the absence of oxidants
SCV17 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the absence of oxidants
SCV20 SH1000-derived Gmr SCV with auxotrophy for CO2; isolated in the absence of oxidants
SCV21 SH1000-derived Gmr SCV without auxotrophy for Men, Hem, Thy, CO2, or fatty acids; isolated in the
absence of oxidants
SCV1036 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the absence of oxidants
SCV1045 Single nucleotide deletion in menA, leading to a premature stop codon after 184 amino acids
SCV1047 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the absence of oxidants; single nucleotide
polymorphism in menF, resulting in A367D substitution of a highly conserved alanine
SCV1057 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the presence of H2O2; single nucleotide
deletion in menE, leading to a premature stop codon after 205 amino acids
SCV1058 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the presence of H2O2; single nucleotide
deletion in menB, leading to a premature stop codon after 113 amino acids
SCV1060 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the presence of H2O2; single nucleotide
polymorphism in menE, leading to a premature stop codon after 165 amino acids
SCV1072 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the presence of paraquat; single
nucleotide polymorphism in menE, leading toa premature stop codon after 373 amino acids
SCV1072 katA::Tn SCV1072 transduced with DNA from NE1366, resulting in inactivation of catalase; Eryr
SCV1077 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the presence of paraquat; single
nucleotide polymorphism in menF, resulting in T79K substitution
SCV1080 SH1000-derived Gmr SCV with auxotrophy for Men; isolated in the presence of paraquat; single
nucleotide polymorphism in aroB, resulting in H241Q substitution of a highly conserved histidine
likely involved in metal binding
SH1000t SH1000-derived Tcr strain geh::pTM304 22
MJH502 SH1000 sigB::Tc 66
SH331 SH1000 rexA::Tn This study
SH445 SH1000 umuC::Tn
SH805 SH1000 recA::Tn
SH1012 SH1000 rexB::Tn
SH1366 SH1000 transduced with DNA from NE1366, resulting in inactivation of catalase; Eryr This study
SH1866 SH1000 dinB::Tn
SH445/pCN34 SH1000 umuC::Tn transformed with pCN34
SH445/pumuC SH1000 umuC::Tn transformed with pumuC
USA300 LAC LAC strain of the USA300 CA-MRSA lineage 85
USA300 hemB USA300 in which hemB has been deleted 35
USA300 hemB geh::pCL55 USA300 hemB mutant with pCL55 integrated into the geh locus This study
USA300 hemB geh::phemB USA300 hemB mutant with phemB integrated into the geh locus, restoring wild-type phenotype
USA300 menD USA300 in which menD has been deleted 35
USA300 menD geh::pCL55 USA300 menD mutant with pCL55 integrated into the geh locus This study
USA300 menD geh::pmenD USA300 menD mutant with pmenD integrated into the geh locus, restoring wild-type phenotype
USA300 JE2 USA300 cured of plasmids 61
(Continued on following page)
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accordance with the manufacturer’s instructions and the use of a standard
plot.
Whole-genome sequencing. DNA was extracted from wild-type
SH1000 and derived SCVs using lysostaphin and phenol-chloroform ex-
traction (46). Purified DNA was sheared into fragments of150 bp and
sequenced using an Illumina MiSeq DNA sequencer. The sequences ob-
tained yielded100-fold coverage.
RESULTS
Culture of S. aureus in the presence of hydrogen peroxide leads
to a specific and dose-dependent increase in the size of the SCV
subpopulation. To determine the effect of oxidative stress on the
size of the gentamicin-resistant SCV subpopulation, S. aureus was
cultured in the presence of increasing concentrations of H2O2,
paraquat, or diamide, which have previously been shown to trig-
ger distinct changes in the staphylococcal proteome (53).
We used an inoculum size (	105 ml1) that was predicted to
not contain SCVs due to their low frequency in the population.
Therefore, SCVs that appeared in the cultures were generated by
the acquisition of mutations in wild-type cells (22).
Increasing concentrations of H2O2 or paraquat, but not di-
amide, led to dose-dependent increases in the size of the gentam-
icin-resistant SCV subpopulation, which was up to 50-fold greater
than in the absence of oxidative stress (Fig. 1A, B, and C). Similar
effects of H2O2 (1 mM) and paraquat (5 mM) on the gentamicin-
resistant SCV subpopulation were also observed for genetically
diverse S. aureus strains USA300 LAC, Wood, and MRSA252
(Fig. 1D).
Paraquat generates superoxide radicals, which S. aureus can
convert to H2O2 via superoxide dismutases (43). To determine
whether the effect of paraquat on SCV numbers was due to H2O2
or superoxide production, S. aureuswas cultured with paraquat in
the presence or absence of purified bovine catalase (10 g ml1).
The presence of exogenous catalase abrogated the effect of para-
quat on SCV subpopulation expansion, indicating that H2O2 pro-
duction, rather than superoxide, was responsible for the increased
SCV frequency (Fig. 1E). However, it is possible that superoxide
enhances H2O2-mediated damage by increasing free iron levels in
the cell (54).
To investigate the nature of the recovered SCVs, representative
colonies from independent cultures containing H2O2 or paraquat
(n  6) were examined, and each was found to have a typical SCV
phenotype, with reduced pigmentation, and were classified as mena-
dione auxotrophs (Fig. 1F). Whole-genome sequencing of a selection
of each of the independently isolated menadione-auxotrophs (two
from TSB only, three from TSB plus H2O2, and three from TSB plus
paraquat) revealed mutations in genes in the menaquinone biosyn-
thetic pathway (aroB and menABDEF) (Table 1) (55). These muta-
tions were similar to those reported previously in clinical isolates and
confirm that the SCV phenotype was due to genetic changes rather
than to epigenetic effects or the physiological response of the bacte-
rium to oxidative stress (15, 17).
SCVsemergeduringH2O2-inducedbacteriostasis.To under-
stand how H2O2 modulates the size of the SCV subpopulation, we
monitored the population dynamics of S. aureus during growth in
the absence or presence of H2O2. As reported previously, wild-
type S. aureus grew rapidly in the absence of H2O2 and produced a
small SCV subpopulation during the early exponential phase (Fig.
2A) (22). In contrast, there was no change in total CFU counts in
the presence of 1 mM H2O2, resulting in an extended lag phase
that lasted until the H2O2 concentration was reduced to	400M
(presumably due to the action of catalase and/or alkyl hydroper-
oxidase [40]). Once the H2O2 concentration was reduced, S. au-
reus replication began at a similar rate to that seen in the absence of
H2O2 (Fig. 2A).
We hypothesized that the elevated rate of SCV emergence in
the presence of H2O2 was either due to switching of wild-type
bacteria into SCVs or, despite the small inoculum size, the repli-
cation of a very few SCVs present in the inoculum. To test whether
SCVs could replicate in the presence of H2O2, we inoculated broth
containing 1 mM H2O2 with a mixed population of phenotypi-
cally stable SCVs (including those auxotrophic for menadione,
hemin, fatty acids, and those without identified auxotrophy) that
TABLE 1 (Continued)
Bacterial strain Relevant characteristicsa
Source or
reference
NE331 USA300 JE2 rexA::Tn
NE445 USA300 JE2 umuC::Tn
NE805 USA300 JE2 recA::Tn
NE1012 USA300 JE2 rexB::Tn
NE1366 USA300 JE2 katA::Tn
NE1866 USA300 JE2 dinB::Tn
CX003SCV Clinical Men-auxotroph SCV This study
CX003WT Revertant of CX003SCV with wild-type phenotype
CX004SCV Clinical Men auxotroph SCV
CX004WT Revertant of CX004SCV with wild-type phenotype
CX005SCV Clinical Men auxotroph SCV
CX005WT Revertant of CX005SCV with wild-type phenotype
CX006SCVM Clinical Men auxotroph SCV
CX006SCVH Clinical Hem auxotroph SCV
CX006WT Revertant of CX005SCVM with wild-type phenotype
CX009SCV Clinical Hem auxotroph SCV
CX009WT Revertant of CX009SCV with wild-type phenotype
Wood Wild-type NCTC 7121
MRSA252 Wild-type 86
a Gmr, gentamicin resistance; Tcr, tetracycline resistance; Eryr, erythromycin resistance; Hem, hemin; Men, menadione; Thy, thymidine.
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represent the composition of SCVs found in cultures not exposed
to oxidants and then monitored growth. Similar to wild-type bac-
teria, the growth of the SCV population was inhibited by 1 mM
H2O2, leading to an extended lag phase relative to SCV growth in
the absence of H2O2 (Fig. 2B). However, as seen for the wild-type
population, once the concentration of H2O2 fell to 400 M,
SCV replication began (Fig. 2B). Because menadione-auxotrophic
SCVs were the predominant SCV type isolated from cultures ex-
posed to H2O2, we undertook a similar experiment to that de-
scribed in Fig. 2B using a stable menadione auxotroph isolated
from a culture exposed to paraquat (SCV1072). As for the wild-
type and the mixed SCV inoculum, SCV1072 did not initiate rep-
lication until the H2O2 concentration had fallen to400M (Fig.
2C). Therefore, SCV replication is not a viable explanation for the
appearance of SCVs at early time points in cultures exposed to
H2O2, when the oxidant is at concentrations inhibitory to staph-
ylococcal growth.
SCV emergence in the presence of H2O2 is dependent upon
mutagenic DNA repair. Because mutations have been shown to
occur in stressed, nonreplicating E. coli cells via DNA double-
strand break repair and the SOS response, which is strongly in-
duced in S. aureus upon exposure to H2O2, we hypothesized that
this may provide a mechanism for the emergence of SCVs under
growth-inhibitory conditions (56–60). To test this, we utilized the
NARSA transposon library to identify genes that were important
for mutagenic DNA repair in the USA300 background (61). Wild-
type and transposon mutants deficient in genes associated with
DNA repair and the SOS response, including recombinase A
(recA::Tn), error-prone polymerases IV or V (dinB::Tn, umuC::
Tn), and rexAB (functionally equivalent to recBCD inE. coli), were
grown in the absence or presence of H2O2. Several mutants, in-
cluding recA and rexABmutants, displayed increased sensitivity to
H2O2, confirming a role in repair of damage caused by oxidative
stress (data not shown). However, this increased sensitivity re-
quired a lower concentration of H2O2 (0.05 mM) to be used in
these experiments compared to that of Fig. 1 and 2. Nonetheless,
even at these reduced concentrations, H2O2 resulted in an increase
in SCV frequency of10-fold in wild-type S. aureus populations
(Fig. 3A). In contrast, H2O2 exposure had no effect on the size of
the SCV subpopulations of the umuC::Tn, recA::Tn, rexA::Tn, or
rexB::Tn mutants relative to cultures without oxidant (Fig. 3A),
indicating that double-strand break repair and the SOS response is
required for SCV emergence during H2O2 exposure but not in its
absence. In contrast, the mutant lacking functional dinB (which is
not part of the S. aureus SOS regulon [62]) had only a slight defect
in H2O2-induced SCV formation (Fig. 3A).
These findings were concordant with measurements of the muta-
tion rate in S. aureus grown with or without H2O2, which showed
that H2O2 exposure increased the mutation rate5-fold in wild-
type S. aureus but had no effect on the mutation rate of strains
FIG 1 Hydrogen peroxide exposure leads to a specific, dose-dependent increase in the size of the SCV subpopulation. (A to C) S. aureus SH1000 was cultured
in increasing concentrations of H2O2 (A), paraquat (B), or diamide (C) for 16 h, and the sizes of the total and SCV populations were determined. (D) The effect
of H2O2 (1 mM) or paraquat (5 mM) on the size of the SCV subpopulations of strains USA300 LAC (LAC), Wood, and MRSA252 (252) were also determined.
None of the oxidants used affected the size of the total population at the concentrations used (data not shown). (E) Wild-type S. aureus SH1000 was incubated
in the absence () or presence () of paraquat and/or catalase, and the sizes of the total (open bars) and SCV populations (closed bars) were determined. (F)
Colony morphology of wild-type S. aureus SH1000 (top left panel) and a representative menadione-auxotrophic SH1000-derived SCV (SCV1072) isolated from
a culture containing paraquat (top right panel). The lack of pigment in the SCV seen on agar plates (top right panel) was also seen after liquid culture (bottom
left panel). Culture of this SCV isolate in the presence of menadione restored pigmentation, indicating deficiencies in menaquinone production (bottom right
panel) (2). Values which are significantly different (P 	 0.05 [Student t test]) from oxidant-free conditions are indicated (*). These data represent the mean
averages of 12 independent cultures. Error bars represent the standard deviations of the mean.
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defective for rexAB or polymerase V (Fig. 3B). There was a modest
(	3-fold) increase in the mutation rate of the recA::Tn mutant,
but this was still significantly reduced compared to the wild-type
(Fig. 3B). In contrast, there was no decrease in H2O2-induced
mutation in S. aureus lacking polymerase IV (dinB) (Fig. 3B).
To ensure that these findings also applied to the SH1000 ge-
netic background, DNA from recA::Tn, rexA::Tn rexB::Tn, dinB::
Tn, and umuC::Tn was transduced into SH1000. Each of the DNA
repair mutants behaved in a very similar manner to that described
above for the USA300 mutants. Specifically, the mutants were
defective for H2O2-induced SCV formation or mutation, with the
exception of dinB::Tn (Fig. 3C and D). Complementation of the
umuC coding sequence, under the control of the native promoter,
to the umuC::Tn mutant restored H2O2-induced mutation and
SCV formation, while the umuC::Tn mutant transformed with
vector alone was defective for H2O2-induced mutation and SCV
formation (Fig. 3C and D).
In E. coli, stress-induced mutation requires both the SOS re-
FIG 2 SCV emergence inS. aureus populations exposed to a bacteriostatic concentration of H2O2. (A) The numbers of wild-type (circles) and SCV (squares) CFU
ml1 were measured over time in the absence (open symbols) or presence (closed symbols) of 1 mM H2O2 (left axis). The concentration of H2O2 was also
measured over time (dashed line, right axis). (B) The growth of a mixed population of phenotypically stable SCVs in the absence (open symbols) or presence
(closed symbols) of H2O2 was also measured over time, together with the concentration of H2O2 (dashed line, axes as for panel A). (C) Growth of a single
menadione-auxotrophic SCV (SCV1072) over time in the absence (open symbols) or presence (closed symbols) of H2O2. The concentration of H2O2 is indicated
by the dashed line and the right-hand axis. The data points represent the mean average of 12 independent cultures. Error bars represent the standard deviations
of the mean.
FIG 3 Expansion of the SCV subpopulation in response to H2O2 requires error-prone polymerase V under the control of the SOS regulon. (A) Frequency of SCVs in
populations of WT S. aureusUSA300 or transposon mutants lacking functional polymerase V (umuC::Tn), RecA (recA::Tn), polymerase IV (dinB::Tn), or RexAB
(rexA::Tn and rexB::Tn) in the absence (open bars) or presence of H2O2 (filled bars). (B) Mutation rate of strains detailed in panel A grown in the absence (open
bars) or presence (closed bars) of H2O2. (C and D) As for panels A and B but with strains constructed in the SH1000 background. In addition, panels C and D
show data from the umuC::Tn mutant transformed with pCN34 only or pCN34 containing the umuC gene and promoter region (pumuC). (E) Total (WT) and
SCV CFU counts from a SH1000-derived sigB mutant (MJH502) grown in the absence (CTL) or presence of paraquat (para). (F) Mutation rate of wild-type
SH1000 (WT) and an SH1000-derived sigB mutant (sigB) grown in the absence (open bars) or presence (closed bars) of H2O2. The data in panels A, C, and E
represent the mean averages of 12 independent cultures, and error bars represent the standard deviation of the mean. Values in panels B, D, and F represent the
mutation rate as determined by fluctuation analysis, and error bars represent the 95% confidence intervals. Values which are significantly different (P 	 0.05
[Student t test corrected for multiple comparisons via the Bonferroni method]) in the presence of H2O2 by comparison to those obtained in the absence of
oxidants are indicated (*).
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sponse and a second signal via the RpoS sigma factor, which is part
of the general stress response (63). Therefore, we considered the
possibility that this may also be the case in S. aureus, especially
since previous work has indicated that the alternative sigma factor
SigB is required for SCV emergence in the presence of antibiotics
(64, 65). However, the absence of SigB did not prevent an SCV
population increase in the presence of 0.1 mM paraquat (Fig. 3E),
and the sigB mutant was not defective for a paraquat-induced
increase in the mutation rate (Fig. 3F). Therefore, SigB does not
appear to be required for oxidative-stress-induced mutation in S.
aureus. It should be noted, however, that we were unable to test
higher concentrations of paraquat or H2O2 at any concentration
used in Fig. 1 due to the increased sensitivity of the sigB mutant to
oxidative stress (66). Taken together, these data demonstrate that
components of the SOS response trigger switching from the wild-
type to SCV phenotype via mutagenic DNA repair, which explains
the emergence of SCVs in the presence of H2O2.
H2O2 selects for phenotypically stable SCVs, enhancing pop-
ulation expansion via replication. The data presented in Fig. 2A
demonstrate that the SCV subpopulation emerged in the presence
of H2O2 and continued to expand after the concentration of the
oxidant fell below the growth-inhibitory concentration. However,
it was not clear whether SCV population expansion at growth-
permissive concentrations of H2O2 was predominantly due to the
replication of a few SCVs generated by mutagenic DNA repair or
was due to a very high rate of phenotype-switching from the wild-
type to the SCV phenotype.
To investigate this, culture medium with or without oxidants
was inoculated with105 CFU tetracycline-sensitive (Tets) wild-
type S. aureus ml1 and 10 CFU SCVs from tetracycline-resis-
tant SH1000 (Tetr) ml1 and grown for 24 h. It should be noted
that the mixed SCV subpopulation arose in cultures that had not
been exposed to oxidants.
As expected, the size of the SCV subpopulation in cultures
containing oxidants was greater than those without oxidants (Fig.
4A). In the absence of oxidative stress, the percentage of SCVs that
were tetracycline resistant fell from 100% in the inoculum to ca.
20% in the mature culture, indicating that 80% of the final SCV
subpopulation had arisen via phenotype switching from the tetra-
cycline-sensitive wild-type population (Fig. 4B), i.e., SCVs revert
at high frequency in the absence of oxidative stress. In contrast, in
the presence of H2O2 or paraquat, the percentage of tetracycline-
resistant SCVs at 24 h were ca. 60% each, indicating that these
oxidative stresses select for maintenance of the SCV phenotype
and that SCV reversion to the wild type does not occur at a high
frequency in the presence of oxidants (Fig. 4B).
It has been shown previously that SCV replication is associated
with an increase in phenotypic stability, since unstable SCVs re-
vert to the wild-type (22). To test whether oxidants select for SCV
stability, we used a previously described stability assay (22) and
FIG 4 Hydrogen peroxide selects for the SCV phenotype. (A) Tryptic soy broth aliquots were inoculated with 105 CFU tetracycline-sensitive wild-type S. aureus
SH1000 and 10 CFU tetracycline-resistant SCVs in the absence (TSB) or presence of either H2O2 or paraquat (para), and the sizes of the total (open bars) and SCV
(filled bars) populations were determined after 16 h of culture. (B) After 16 h of culture, the percentage of SCVs that were resistant to tetracycline was determined.
Values significantly (P 	 0.05 [Student t test]) different from those obtained with bacteria cultured in the absence of oxidants (TSB) are indicated (*). Bars
represent the mean averages of 12 independent cultures. Error bars represent the standard deviations of the mean. (C, D, and E) The relative stability of SCVs
isolated from cultures without (TSB) (C) or with H2O2 (D) or paraquat (para) (E) were determined by using a previously described assay (22). Individual SCVs
were classified as stable (stab), partially stable (part), or unstable (unst) as described in Materials and Methods. The data points represent a single independent
culture. The percentag of SCVs classified as unstable was significantly lower in cultures containing oxidants than those without (an asterisk [*] indicates a
significant difference relative to TSB without oxidants). (F and G) SCVs that were incubated either in the absence (F) or presence (G) of a subinhibitory
concentration of H2O2 were assessed for phenotypic stability. Each data point represents a single independent culture. SCVs that were exposed to H2O2 or
paraquat were significantly more stable than those incubated in TSB alone. Each data point represents a single culture (10 from each condition). Significant
differences between each stability category (P	 0.05 [Student t test corrected for multiple comparisons via the Bonferroni method]) are indicated (*).
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found that SCVs that arose in cultures exposed to H2O2 or para-
quat were significantly more stable than those that arose in broth
only (Fig. 4C, D, and E). We then generated a pool of SCVs that
had arisen spontaneously in cultures not exposed to oxidants and
then grew them in the absence or presence of H2O2. Oxidative
stress resulted in significantly increased SCV stability, demon-
strating that H2O2 selects for SCV stability regardless of whether
SCVs arose via the SOS response or spontaneously (Fig. 4F and G).
Therefore, the exposure of SCVs to oxidants results in enhanced
stability, which reduces reversion to the wild-type and thus en-
ables SCV population expansion via replication.
Nonoxidative SOS induction promotes SCV reversion to the
wild type. The data presented in Fig. 4 strongly suggest that H2O2
selects for phenotypically stable SCVs, which was surprising be-
cause activation of the SOS response would be expected to in-
crease the frequency of suppressor mutations which promote SCV
reversion to the wild-type phenotype. This suggests that the selec-
tive pressure exerted by oxidants on SCVs is great enough to over-
come the increased mutation rate caused by induction of the SOS
response.
However, we considered two alternative explanations for the
enhanced stability of SCVs exposed to oxidative stress: that SCVs
generated by the SOS response are inherently more stable than
those that arise spontaneously or that the SOS response cannot
trigger reversion of SCVs to wild-type bacteria.
To test these possibilities, we used the antibiotic ciprofloxacin,
which induces a very similar DNA damage repair to that described
upon H2O2 exposure (56, 62). Exposure of wild-type but not
umuC::Tn mutant bacteria to a subinhibitory concentration of
ciprofloxacin led to an increase in SCV frequency, confirming that
induction of the SOS response promotes SCV emergence via mu-
tagenic DNA repair (Fig. 5A). However, the SCVs triggered by
ciprofloxacin were no more stable than those which emerged in
the absence of the antibiotic (Fig. 4C and 5B). This demonstrates
that SCVs generated via the SOS response are not inherently more
stable than those that arise spontaneously during bacterial repli-
cation. We then tested whether the SOS response can promote
SCV reversion to the wild type by exposing a panel of SCVs with
various levels of stability to ciprofloxacin or paraquat. In five of
the seven SCVs examined, ciprofloxacin exposure promoted the
frequency of reversions, indicating that SOS induction can indeed
promote SCV reversion to the wild type (Fig. 5C). In contrast,
exposure of each of the SCVs to paraquat using the same assay
either had no effect or reduced SCV reversion frequency (Fig. 5C).
Therefore, while both ciprofloxacin and paraquat stress trigger the
SOS mutagenic repair pathway, only the antibiotic promotes bi-
directional switching between the wild type and SCVs. In contrast,
oxidative stress triggers wild-type-to-SCV switching but selects
against SCV reversion to the wild type.
Finally, we examined whether loss of mutagenic DNA repair
affected SCV stability in the absence of SOS-inducing stresses.
This revealed that SCVs generated by the umuC::Tn mutant in the
SH1000 background were as stable as those that arise in the wild
type, demonstrating that the SOS response does not play a role in
SCV emergence or reversion in the absence of genotoxic stresses
(Fig. 4C and 5D).
SCVs are less susceptible to H2O2 than parental strains. Pre-
vious work has suggested that SCVs should be more susceptible to
H2O2 than wild-type bacteria due to the lack of staphyloxanthin
pigment and reduced catalase activity in heme auxotrophs (19, 36,
37, 45). However, since H2O2 selected for the SCV phenotype we
considered the possibility that SCVs are in fact less sensitive to
oxidative stress than wild-type bacteria. To test this, the survival of
wild-type SH1000 in the presence of 30 mM H2O2 was compared
to a phenotypically stable SCV isolate that arose in the presence of
paraquat (SCV1072). This revealed that survival of the SCV was
significantly greater than that of the wild type (Fig. 6A). Further
analyses of three stable menadione-auxotrophic SCVs from inde-
pendent cultures containing either H2O2 or paraquat revealed that
each SCV isolate was significantly more resistant to H2O2 killing
than the WT strain (Fig. 6B). Because culture in the presence of
H2O2 or paraquat may have selected for mutations that confer
elevated resistance to oxidative stress, three additional, indepen-
dently isolated menadione-auxotrophic SCVs, which arose in
broth without oxidants, were assessed. These showed similarly
high levels of resistance to H2O2 killing (Fig. 6B), suggesting that
H2O2 resistance is an intrinsic property of menadione-auxotro-
phic SCVs.
To determine whether resistance to H2O2 killing was related to
the auxotrophic phenotype a panel of SCVs, isolated from gen-
tamicin-containing media, with various or unknown auxotro-
phies was assessed for resistance to H2O2 killing. All of these iso-
lates were significantly more resistant to H2O2 killing than the
wild-type strain (Fig. 6C).
FIG 5 Ciprofloxacin promotes bidirectional phenotype-switching. (A) Wild-
type SH1000 and a umuC mutant were grown in the absence () or presence
() of a subinhibitory concentration of ciprofloxacin for 16 h, and the fre-
quency of gentamicin-resistant SCVs was determined. The data represent the
mean average of 10 independent cultures, and error bars represent the stan-
dard deviations. Values which differ from those seen in media lacking cipro-
floxacin are highlighted (*). (B) Stability of SCV isolates that arose in wild-type
SH1000 populations in the presence of ciprofloxacin (n  6). The data are
presented and analyzed as described in the legend to Fig. 4. (C) The frequency
of SCV reversion to the wild type was determined in the absence (CTL) or
presence of ciprofloxacin (Cipro) or paraquat (Para). Reversion rates that
differ from the those found on media without supplements are highlighted (*).
(D) Stability of SCVs that arose in the umuC background in the absence of
oxidants or ciprofloxacin (n 8).
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We also considered the possibility that gentamicin-resistant
SCVs may consistently accumulate mutations which decrease sus-
ceptibility to H2O2. To test this, menadione-auxotrophic SCV iso-
lates were cultured in the absence or presence of menadione, and
their susceptibility to H2O2 killing was determined. Culture of
menadione-auxotrophic SCVs in the presence of menadione pro-
duced bacteria that were as sensitive as the wild-type parental
strain to H2O2, indicating that secondary mutations are not re-
sponsible for the elevated H2O2 resistance (Fig. 6D). It should be
noted that menadione has been used as a redox cycling agent to
generate superoxide within bacteria. However, the concentrations
typically used in such studies are 1,000-fold greater than those
used here, and there was no significant effect on the viability of the
wild-type bacteria in the presence of H2O2 (2, 67). To further test
whether reduced susceptibility to H2O2 was solely due to defects in
the electron transport chain, S. aureus wild type was cultured in
the presence of the Pseudomonas exoproduct HQNO, which
blocks the electron transport chain of Gram-positive bacteria and
confers an SCV phenotype upon S. aureus (68). Culture of S. au-
reus in the presence of HQNO produced bacteria that were resis-
tant to H2O2 killing (Fig. 6E). However, the presence of HQNO
alone did not alter H2O2 resistance of S. aureus which had been
cultured in the absence of the exoproduct (Fig. 6E). Therefore,
simply blocking the electron transport chain is not protective
against H2O2. Rather, resistance is most likely due to the physio-
logical adaptation of S. aureus to loss of the electron transport
chain.
To ensure that these findings were of clinical relevance, we
assessed the survival of hemB and menD deletion mutants con-
structed in the USA300 community-associated MRSA strain. In
keeping with the data for SH1000, the survival of wild-type
USA300 in the presence of H2O2 was significantly lower than that
of isogenic hemBormenDmutants (Fig. 6F). Complementation of
either mutant with the relevant coding sequence restored the wild-
FIG 6 SCVs are more resistant to H2O2 than wild-type bacteria. (A) The survival of wild-type SH1000 S. aureus (Œ) or a derived SCV isolate () during exposure
to 30 mM H2O2 was determined by quantifying CFU. Survival of the SCV was significantly greater (P	 0.05) than that of the wild type at the 45- and 60-min time
points. (B) Survival of three independently isolated, menadione-auxotrophic SCVs from cultures without (TSB) or with H2O2 or paraquat (para) was determined
after 60 min of exposure to 30 mM H2O2. The survival of the wild type after 60 min is shown for comparison. The survival of all SCV isolates was significantly
greater than that of the wild type. (C) Survival of independently isolated SCVs with auxotrophy for hemin (H), CO2 (C), menadione (M), fatty acids (F), or where
auxotrophy has not been established (?) after 60 min in 30 mM H2O2. (D) Survival of wild-type or various, independently isolated menadione-auxotrophic SCVs
from cultures without oxidants, grown in the absence () or presence () of menadione. Supplementation of SCV but not wild-type cultures with menadione
significantly reduced survival in the presence of H2O2. (E) Growth of S. aureus SH1000 in the presence of the electron-transport chain inhibitor HQNO (Gro)
promotes resistance to H2O2 relative to growth in TSB only (Ctl) or growth in TSB, followed by addition of HQNO to bacteria 5 min prior to H2O2 exposure
(Post). (F) Survival of the USA300 wild-type strain and derived deletion mutants lacking hemB or menD after incubation in 25 mM H2O2. Survival of the SCVs
was significantly greater than WT. (G) Survival after incubation in 25 mM H2O2 of USA300 hemB and menD mutant strains transformed either with pCL55 or
PCL55 containing the hemB (phemB) or menD (pmenD) coding sequences. Survival of complemented strains was significantly lower than that of mutants
transformed with vector alone (pCL55). (H) Survival of a clinical menadione-auxotrophic SCV (CX003SCV) and derived revertant (CX003WT) with the
wild-type phenotype after incubation in 30 mM H2O2. Survival of the SCV was significantly greater than wild-type after 60 min. Significance was determined by
using a Student t test corrected for multiple comparisons via the Bonferroni method and declared significant when P	 0.05.
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type growth phenotype (data not shown) and resulted in de-
creased survival in H2O2, whereas vector alone did not affect
growth or survival (Fig. 6G). Finally, increased H2O2 resistance
was demonstrated in a clinical menadione-auxotrophic SCV iso-
late (CX003SCV), relative to a wild-type revertant (CX003WT)
(Fig. 6H). Therefore, resistance to H2O2 is an inherent property of
electron-transport chain-deficient SCVs that very likely contrib-
utes to their ability to persist within host tissues during chronic
infections.
Elevated catalase activity in SCVs partially explains en-
hanced H2O2 resistance. In addition to staphyloxanthin, catalase
is a major staphylococcal defense against H2O2 and has been re-
ported to be expressed at higher levels in clinical SCVs than wild-
type S. aureus (33, 40–42). However, heme-auxotrophic SCVs
cannot generate functional catalase and SCVs isolated from the
lungs of patients with cystic fibrosis have been reported to have
reduced catalase activity (5, 45).
To resolve the question of catalase activity in electron-trans-
port chain-deficient SCVs, we measured the ability of wild-type S.
aureus SH1000, menadione-auxotrophic SCV isolate SCV1072
and heme-auxotrophic SCV9 to degrade H2O2. This revealed sig-
nificantly elevated catalase activity in the menadione-auxotrophic
SCV relative to the wild type, while the catalase activity of the
heme-auxotrophic SCV was significantly impaired relative to wild
type (Fig. 7A). Similarly, a clinical menadione-auxotrophic SCV
isolate had significantly higher catalase activity than a revertant
isolate with the wild-type phenotype (Fig. 7B). In keeping with
these data, analyses of an additional four clinical SCV isolates and
matching revertants revealed that menadione-auxotrophic SCVs
degraded significantly more H2O2 than revertants, whereas heme
auxotrophs exhibited defective catalase activity (Fig. 7C).
Next, we examined catalase activity in a panel of gentamicin-
resistant SCVs with diverse auxotrophies or no identified auxot-
rophy isolated from broth cultures in the absence of oxidants. In
every case, the catalase activity of the SCV was greater than that of
the wild type, although significant variation was observed between
isolates (Fig. 7D). Finally, to demonstrate that selection for SCVs
does not itself select for elevated catalase activity, we measured
catalase in isogenic menD and hemB mutants and the wild-type
USA300 parent strain. Consistent with the previous data, this re-
vealed that the menD deletion mutant had significantly higher
levels of catalase activity than wild-type USA300, while the hemB
deletion mutant was unable to degrade H2O2 (Fig. 7E) (45). Com-
plementation of the hemB and menD mutants with the relevant
wild-type coding sequence restored catalase activity to wild-type
levels (Fig. 7F).
FIG 7 Most SCVs display elevated catalase production, which partially explains their decreased susceptibility to H2O2. (A) The H2O2 concentration was
measured over time during incubation with SH1000 wild type, menadione-auxotrophic SCV1072 (1072) or heme-auxotrophic SCV9 (9). (B) H2O2 degradation
by a clinical menadione-auxotrophic SCV isolate (SCV) and a revertant with wild-type (WT) phenotype. (C) H2O2 degradation after 30 min of incubation by
clinical SCV isolates auxotrophic for menadione (M) or hemin (H) and paired revertant isolates. (D) H2O2 degradation after 30 min of incubation by
SH1000-derived SCV isolates with diverse or unidentified auxotrophies, including CO2 (C), menadione (M), fatty acids (F), or where auxotrophy has not been
established (?) or does not exist. Wild-type (WT) S. aureus SH1000 is included as a control. (E) H2O2 degradation by wild-type USA300 and menD (menD) and
hemB (hemB) mutants. (F) H2O2 degradation by menD (menD) and hemB (hemB) mutants transformed with plasmids containing the deleted genes (pmenD or
phemB) or vector only (pCL55). (G) H2O2 levels after incubation with SH1000 katA::Tn (katA::Tn) or SCV1072 katA::Tn (1072 katA::Tn) or in the absence of
bacteria (No bact.). (H) Survival of wild-type (WT) SH1000, menadione-auxotrophic SCV1072 (1072), SH1000 katA::Tn (katA::Tn), or SCV1072 katA::Tn (1072
katA::Tn) after incubation in 30 mM H2O2 for 1 h. All data points represent the means of four independent experiments performed in duplicate. Error bars
represent the standard deviations of the mean. Values that are significantly different from the wild type are denoted (*), with the exception of panel F, in which
a significant difference from strains expressing catalase is denoted. Significance was determined by using a Student t test corrected for multiple comparisons via
the Bonferroni method and declared significant when P	 0.05.
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To confirm that the degradation of H2O2 was due to catalase,
rather than alkyl-hydroperoxidase or other peroxidases, we trans-
duced SH1000 WT and SCV1072 with DNA from a USA300
katA::Tn mutant (40). Both strains were completely devoid of cat-
alase activity, confirming the role of catalase (KatA) in the H2O2
breakdown (Fig. 7G).
Next, we sought to determine whether catalase activity ex-
plained the enhanced resistance of menadione-auxotrophic SCVs
to H2O2 (Fig. 6A and B). Wild-type SH1000, SCV1072, SH1000
katA::Tn, and SCV1072 katA::Tn were each exposed to 30 mM
H2O2 for 1 h, and the survival was determined. Strains deficient in
catalase showed increased sensitivity to H2O2 (Fig. 7H). However,
SCV1072 katA::Tn was not as sensitive to H2O2 as SH1000 katA::
Tn, indicating that elevated catalase activity only partially explains
the resistance of menadione-auxotrophic SCVs to H2O2 (Fig. 7H).
Taken together, these data indicate that enhanced catalase ac-
tivity is common to most electron transport chain-deficient SCVs,
with the exception of those that cannot synthesize heme. How-
ever, additional factors beyond catalase contribute to the resis-
tance of SCVs to H2O2, particularly in heme auxotrophs.
DISCUSSION
S. aureus is responsible for a raft of chronic and recurrent infec-
tions despite triggering a potent immune response and antibiotic
therapy (69, 70). During the course of infection, S. aureus fre-
quently acquires mutations which promote survival in host tis-
sues, including those that confer a small-colony variant pheno-
type. The data presented in this report reveal that these mutations
increase in frequency in response to one of the major ROS pro-
duced by neutrophils, H2O2, via the SOS response. These data
support previous work showing that increases in the mutation rate
following DNA damage are due to the action of specific repair
machinery, rather than the DNA damage itself (57–60).
The ability of bacteria to transiently increase mutation rates in
response to environmental stress increases the probability of ben-
eficial (adaptive) mutations that enhance survival (58, 71). Cer-
tainly, the emergence of electron transport chain-deficient SCVs
in response to oxidative stress appears to be beneficial to S. aureus
due to their resistance to oxidative stress and enhanced catalase
production, which may enhance survival and/or replication of
wild-type bacteria via detoxification of H2O2 (Fig. 6 and 7). In
addition, SCVs have a number of other phenotypic properties
which might promote persistence in host tissues, including intra-
cellular survival, strong biofilm formation, and a high degree of
antibiotic tolerance (5, 12, 13, 30–32). Therefore, a single inacti-
vating mutation in the menaquinone biosynthetic pathway has a
profound effect on the phenotype of S. aureus, changing it from a
fast-growing, toxin-producing pathogen to a much less patho-
genic and slow-growing variant that is able to persist within host
tissues for extended periods. However, the close correlation be-
tween mutation rate (as determined by mutations at the rpoB
locus) and SCV emergence indicates that the men operon is prob-
ably not a mutation hot spot, at least with respect to H2O2-asso-
ciated mutations.
In E. coli, stress-induced mutation involves the low-fidelity
polymerases IV and V. Although the ability of a bacterium to
increase the mutation rate is a beneficial tool, the principal func-
tion of these polymerases is the replication of damaged DNA in a
process known as “trans-lesion synthesis,” the low-fidelity nature
of the polymerase enabling it to bypass DNA lesions at the cost of
a high-frequency of base pair mismatches (72). However, it is not
clear whether the increased mutation rate associated with poly-
merases IV and V is simply a consequence of DNA repair or part of
a coevolved mechanism to promote the mutation rate during
times of DNA-damaging stress and thus increase the likelihood of
beneficial mutations arising.
In S. aureus, trans-lesion synthesis appears to make a small
contribution to S. aureus resistance to oxidative stress since the
umuC::Tn mutant lacking polymerase V (but not dinB/polymer-
ase IV) was slightly more sensitive to H2O2 than the wild type
(data not shown). These data fit with previous work which shows
that the expression of umuC, but not dinB, is increased in response
to H2O2 (56). Therefore, in S. aureus, the expression of polymer-
ase V appears to facilitate efficient repair of H2O2-mediated DNA
damage. However, this does not rule out the possibility that poly-
merase V is part of a coevolved mechanism to increase the muta-
tion rate in response to environmental stress. For example, umuC
is one of the most strongly expressed genes in response to various
genotoxic stresses, and this may result in greater polymerase V
production than is strictly necessary to repair the damaged DNA
(56, 62, 73).
Although H2O2 exposure led to large increases in SCV fre-
quency, this was not solely due to an elevated mutation rate but
also to the subsequent replication of emergent SCVs. H2O2 se-
lected for the SCV phenotype, which may reflect the enhanced
resistance of SCVs to H2O2, coupled with enhanced catalase pro-
duction. Therefore, with the possible exception of heme auxo-
trophs, which lack catalase activity, gentamicin-resistant SCVs ap-
pear to be well equipped to persist in environments with a high
burden of ROS. This correlates with the clinical evidence that
SCVs are able to persist in host tissues, resisting clearance by im-
mune cells that expose the pathogen to the oxidative burst (1–14,
36, 37).
The discovery of enhanced catalase activity in non-heme-
auxotrophic SCVs is in keeping with a transcriptomic study of
clinical SCV isolates, which reported enhanced katA expression
(33). Also in keeping with previous work, proteomics analysis of
clinical and in vitro selected heme-auxotrophic SCVS revealed re-
duced catalase than in corresponding wild-type bacteria (74).
Therefore, it appears that loss of the electron transport chain re-
sults in enhanced expression of katA, leading to elevated catalase
activity, except where heme biosynthesis is defective (33, 74). The
reason why catalase activity is elevated in menadione auxotrophic
SCVs is under investigation but may reflect the significantly al-
tered metabolic profile of these mutants, which results in altered
production of virulence factors and defense molecules such as
staphyloxanthin (discussed below) (8, 9, 14, 19, 28, 30, 36, 45). It
could, therefore, be hypothesized that enhanced catalase activity is
a compensatory mechanism for the loss of staphyloxanthin, but
this remains to be tested.
Although there appear to be a number of different pathways by
which electron transport chain-deficient SCVs can arise (resulting
in diverse auxotrophies), cultures exposed to H2O2 consistently
generated menadione auxotrophs. Since menadione auxotrophs
were no more resistant to H2O2 and produced similar levels of
catalase to other SCVs (with the exception of heme auxotrophs),
this is most likely explained by the increased likelihood of this
variant arising relative to others. Specifically, menadione-auxo-
trophic SCVs can arise via inactivating mutations anywhere in the
menaquinone biosynthetic pathway, whereas other types of SCV
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might only arise via mutations in much smaller loci. In support of
this hypothesis, in cultures not exposed to H2O2, menadione-
auxotrophic SCVs were the most abundant (40%), followed by
heme auxotrophs (35%). Therefore, it appears that H2O2 selects
for catalase producing SCVs, of which menadione auxotrophs are
the most abundant, over the catalase-deficient heme auxotroph.
While SCVs are resistant to oxidative stress and have many
phenotypic properties which promote survival in host tissues,
these come at the cost of slow growth and loss of exotoxin pro-
duction (2, 4, 6, 9, 13, 35). Therefore, S. aureus populations must
provide a balance between fast-growing, toxin-producing wild-
type bacteria which are essential for the establishment of infection
and slow-growing non-toxin-producing SCVs, which are able to
resist threats such as oxidative stress or antibiotics. Indeed, such a
strategy parallels the formation of antibiotic tolerant persister cells
(75, 76). Balaban et al. showed that persister cells arise stochasti-
cally during growth (type I) and that the frequency increases in
response to specific environmental stresses such as subinhibitory
concentrations of antibiotics (type II) (75, 77). The production of
persister cells prior to antibiotic exposure is hypothesized to be a
bet-hedging strategy to ensure the population against exposure to
lethal concentrations of antimicrobials that would otherwise erad-
icate the entire population (75–79).
Although SCVs arise via mutation and persister cells via
changes in the physiological state of cells, both events are stochas-
tic in nature and the frequency of these events is influenced by
genetic factors and there are, therefore, clear parallels in their
emergence within populations (77). We have previously shown
that SCVs emerge constitutively in replicating S. aureus cultures
(type I) and in this report demonstrate that a specific environmen-
tal stress enhances SCV emergence and population size via the
action of specific gene products (type II) (22). Therefore, we hy-
pothesize that SCVs comprise a bet-hedging strategy against lethal
oxidative and antibiotic stress in a similar way to persisters ensur-
ing populations against bactericidal antibiotics. A key part of such
an ensurance policy is the ability to restore the population of wild-
type bacteria, which SCVs can do via the repair of mutations or
acquisition of suppressor mutations that restore the function of
mutated gene products (15, 17). In addition, activation of the SOS
mutagenic repair pathway via subinhibitory ciprofloxacin (but
not oxidative stress) can promote SCV reversion to the wild type.
The very high resistance of SCVs to concentrations of H2O2
that are lethal to the wild type was a surprising finding given the
reduced pigmentation (and catalase levels in the hemin auxo-
troph). The SCVs that arose under oxidative stress were gentami-
cin resistant and consistently auxotrophic for menadione, indicat-
ing loss of menaquinone biosynthesis and thus interruption of the
electron transport chain (2, 9).
The ability of electron transport chain-deficient bacteria to re-
sist H2O2 is in apparent contrast to previous work which showed
that blockage of the electron transport chain of E. coli using KCN,
or disruption of the menA gene, resulted in increased susceptibil-
ity to H2O2 (80). Loss of the electron transport chain in E. coli led to
a significant increase in reducing power inside the cell, which
propagates the highly damaging Fenton reaction by reducing iron
(80). Our experiments with HQNO demonstrate that SCV resis-
tance to H2O2 is not simply a function of a defective electron
transport chain. Rather, it is only when S. aureus has been cultured
in the absence of a functional electron transport chain that it is
able to survive subsequent H2O2 challenge. Although this is par-
tially due to catalase activity, additional factors promote the resis-
tance of electron transport chain-deficient S. aureus to H2O2. For
example, S. aureus can avoid redox stress during loss of the elec-
tron transport chain by switching to fermentative metabolism via
the redox-regulatory element Rex (81–83). Metabolic and tran-
scriptomic analyses of SCVs reveal a huge increase in lactate and
alcohol dehydrogenase activity, and this maintains redox balance
in the cell, preventing an accumulation of reducing power (14, 30,
83). Furthermore, it is possible that fermentative metabolism ren-
ders SCVs more resistant to H2O2 killing by reducing the need for
iron-containing metabolic enzymes in the cytoplasm, as well as
cytochromes. In support of this hypothesis, wild-type S. aureus
exposed to H2O2 increase expression of genes associated with fer-
mentation and a Staphylococcus epidermidis mutant lacking a
functional TCA cycle displayed elevated resistance to H2O2 killing
(54, 55, 84).
Taken together, the data presented here reveal an additional
strategy by which S. aureus can promote its survival under condi-
tions of oxidative stress via the production of small-colony vari-
ants in response to H2O2 exposure. In addition to ensuring the
population against potentially lethal oxidative stress, elevated
SCV production is likely to promote persistent infection via re-
duced susceptibility to antibiotic therapy, increased biofilm for-
mation, and enhanced intracellular persistence.
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